These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28237878)

  • 1. A tissue dose-based comparative exposure assessment of manganese using physiologically based pharmacokinetic modeling-The importance of homeostatic control for an essential metal.
    Gentry PR; Van Landingham C; Fuller WG; Sulsky SI; Greene TB; Clewell HJ; Andersen ME; Roels HA; Taylor MD; Keene AM
    Toxicol Appl Pharmacol; 2017 May; 322():27-40. PubMed ID: 28237878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of an essential element: manganese.
    Santamaria AB; Sulsky SI
    J Toxicol Environ Health A; 2010; 73(2):128-55. PubMed ID: 20077284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of PBPK models in estimating human brain tissue manganese concentrations.
    Ramoju SP; Mattison DR; Milton B; McGough D; Shilnikova N; Clewell HJ; Yoon M; Taylor MD; Krewski D; Andersen ME
    Neurotoxicology; 2017 Jan; 58():226-237. PubMed ID: 27989617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modeling of manganese in the rat IV: Assessing factors that contribute to brain accumulation during inhalation exposure.
    Nong A; Teeguarden JG; Clewell HJ; Dorman DC; Andersen ME
    J Toxicol Environ Health A; 2008; 71(7):413-26. PubMed ID: 18306088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling.
    Nong A; Taylor MD; Clewell HJ; Dorman DC; Andersen ME
    Toxicol Sci; 2009 Mar; 108(1):22-34. PubMed ID: 19098275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development.
    Yoon M; Schroeter JD; Nong A; Taylor MD; Dorman DC; Andersen ME; Clewell HJ
    Toxicol Sci; 2011 Aug; 122(2):297-316. PubMed ID: 21622944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models.
    Schroeter JD; Nong A; Yoon M; Taylor MD; Dorman DC; Andersen ME; Clewell HJ
    Toxicol Sci; 2011 Apr; 120(2):481-98. PubMed ID: 21205636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water.
    Song G; Van Landingham CB; Gentry PR; Taylor MD; Keene AM; Andersen ME; Clewell HJ; Yoon M
    Toxicol Appl Pharmacol; 2018 Nov; 359():70-81. PubMed ID: 30243844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganese.
    Perry CS; Blanchette AD; Vivanco SN; Verwiel AH; Proctor DM
    Regul Toxicol Pharmacol; 2023 Dec; 145():105518. PubMed ID: 37863417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model.
    Yoon M; Nong A; Clewell HJ; Taylor MD; Dorman DC; Andersen ME
    Toxicol Sci; 2009 Nov; 112(1):44-58. PubMed ID: 19726578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactational transfer of manganese in rats: predicting manganese tissue concentration in the dam and pups from inhalation exposure with a pharmacokinetic model.
    Yoon M; Nong A; Clewell HJ; Taylor MD; Dorman DC; Andersen ME
    Toxicol Sci; 2009 Nov; 112(1):23-43. PubMed ID: 19726576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese accumulation in nail clippings as a biomarker of welding fume exposure and neurotoxicity.
    Sriram K; Lin GX; Jefferson AM; Roberts JR; Andrews RN; Kashon ML; Antonini JM
    Toxicology; 2012 Jan; 291(1-3):73-82. PubMed ID: 22085607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating physiologically based pharmacokinetic models for manganese by incorporating rapid association/dissociation processes in tissues.
    Yoon M; Efremenko A; Van Landingham C; Gentry PR; Keene AM; Taylor MD; Clewell HJ; Andersen ME
    Toxicol Appl Pharmacol; 2019 Jun; 372():1-10. PubMed ID: 30978397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a multi-route physiologically based pharmacokinetic model for manganese to evaluate dose-dependent neurological effects in monkeys.
    Schroeter JD; Dorman DC; Yoon M; Nong A; Taylor MD; Andersen ME; Clewell HJ
    Toxicol Sci; 2012 Oct; 129(2):432-46. PubMed ID: 22723044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment.
    Andersen ME; Dorman DC; Clewell HJ; Taylor MD; Nong A
    J Toxicol Environ Health A; 2010; 73(2):217-34. PubMed ID: 20077292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese.
    Andersen ME; Gearhart JM; Clewell HJ
    Neurotoxicology; 1999; 20(2-3):161-71. PubMed ID: 10385880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essentiality, toxicity, and uncertainty in the risk assessment of manganese.
    Boyes WK
    J Toxicol Environ Health A; 2010; 73(2):159-65. PubMed ID: 20077286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese exposure, essentiality & toxicity.
    Santamaria AB
    Indian J Med Res; 2008 Oct; 128(4):484-500. PubMed ID: 19106442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics.
    Teeguarden JG; Gearhart J; Clewell HJ; Covington TR; Nong A; Andersen ME
    J Toxicol Environ Health A; 2007 Sep; 70(18):1515-26. PubMed ID: 17710612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
    Furtaw EJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.